The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical testing have forced the drug manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies while utilizing this synergy to reduce cost.
This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they have.
Scope of this report
It analyzes the market data ( revenues ) of bioinformatics tools, services and content/database in North America, Europe, Asia and rest of the world that includes Middle East, Africa, Russia, Latin America and Australia
Key market drivers, restraints and opportunities for the parent segments and evaluation of respective sub segments with respect to market dynamics.
Covers sequence analysis, sequence alignment, sequence manipulation and structural analysis under tools market along with the sub segments. Service market includes data analysis, database and management and sequencing services.
Provides patent analysis with respect to competitors, geography and technology while analyzing them over the years.
Describes the strategic focus of the market players by evaluating the competitive landscape within the bioinformatics market.
Analyze the markets while giving an overview of Indian and Chinese bioinformatics industry and mutually comparing them.
Key findings from this report
The bioinformatics market growth is highest in the Europe and Asian region, with the European market estimated to compete in the North American bioinformatics market.
North America constitutes the major market share owing to growing demand for bioinformatics tools and technology advancements.
European bioinformatics market is undergoing fast transition from a fragmented market to a consolidated market owing to increasing number of mergers and acquisition taking place.
Sequence analysis tools forms the largest market of the total tools market with its large number of applications in the drug discovery.
Large bioinformatics firms such as Affymetrix and Invitrogen are focusing on acquisitions in order to add more to their product and service portfolio.
Data analysis and sequencing services form the major segment in the bioinformatics service market. Rise in the consultancy services has been the major driving force behind the market growth.
Use this report to:
Understand the emerging technologies and the growth associated for evaluation of potential of the type of product and services.
Understanding the product developments on which the companies are focussing for evaluating the new technological trends.
For evaluation of growth prospective for the bioinformatics applications and determining the lucrative markets.
To gain knowledge about the relative importance of the bioinformatics tools in the next five years for investment opportunities.
Helps in determining the market players’ interest in terms of collaborations and M&A with the related industrial firms which will help a company to explore the untouched areas.
Gives an explanatory overview of business environment between India and China, thereby putting an opportunity for the companies to focus on weak business areas.
Key market issues discussed in this report
The scope for price escalation and product differentiation is low in the drug manufacturing; the manufacturers are concentrating on quality improvement for gaining a competitive edge. Bioinformatics is thereby having growth opportunity due to its accurate analytical ability.
The rising trend is the outsourcing of services in the Asian region due to cheap labor availability and high efficiency. This will boost the market revenues in the countries such as India and China.
Bioinformatics market is widely driven by molecular medicines due to its wide applications in it. Bioinformatics tools help in providing fast and effective treatment which will enhance its applications in the field of molecular medicine.
Saturation of the pharmaceutical markets due to brand domination results in lack of competition. Thereby, there is a lack of stimulus among these companies to adopt new technologies which effects the bioinformatics tools adoption.
High amount of complexity and cost acts as a hinder for the market growth.
Product patent regime is acting as a driving factor for the Indian and Chinese bioinformatics market.
There is a lack of experienced and skilled professionals in Indian bioinformatics market which hinders the future growth.
Key questions answered by this report
What are the important bioinformatics market and their growth over the period 2009-14?
What are the major technologies and services that have emerged in different areas such as genomics data analysis, microarray data analysis, primary sequence analysis and others?
In which areas are the companies focusing while forming strategic alliances with other industrial players?
What is the current potential of bioinformatics applications in the tools and services and what is the future prospective of these applications in the similar scenario?
How does the competitive landscape look like and what is the strategic focus of the industrial players for revenue earnings?
What are the key opportunity areas in the current market scenario and restraining factors hindering the development of bioinformatics?
(0 items)
